← brief for 2026-08-10 · Slowing decline

Safety and efficacy of glucagon like peptide-1 receptor agonism-based therapies in end-stage renal disease: A systematic review and meta-analysis.

Article A Peer reviewed Meta-analysis or large trial

Key takeaways

This review combined the results of many studies on GLP-1 drugs, such as semaglutide, in people with kidney failure, including those on dialysis. Overall, it found these drugs appear safe and effective for this group. Combining many studies makes the finding stronger, though the included studies varied.

Who did this work

Dutta D · Jena S · Mahajan K · Kamrul-Hasan ABM · Bhattacharya S · Mohindra R

Source

Journal article · PubMed — the drug frontier · 2026 Aug 4
https://pubmed.ncbi.nlm.nih.gov/42551699/